168 related articles for article (PubMed ID: 16502003)
21. Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer.
Sundaresan P; Yeghiaian-Alvandi R; Gebski V
J Med Imaging Radiat Oncol; 2010 Feb; 54(1):69-75. PubMed ID: 20377719
[TBL] [Abstract][Full Text] [Related]
22. Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy.
Serizawa T; Iuchi T; Ono J; Saeki N; Osato K; Odaki M; Ushikubo O; Hirai S; Sato M; Matsuda S
J Neurosurg; 2000 Dec; 93 Suppl 3():32-6. PubMed ID: 11143259
[TBL] [Abstract][Full Text] [Related]
23. The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring.
Shen CJ; Rigamonti D; Redmond KJ; Kummerlowe MN; Lim M; Kleinberg LR
Pract Radiat Oncol; 2016; 6(6):409-416. PubMed ID: 27687187
[TBL] [Abstract][Full Text] [Related]
24. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
25. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
27. Managing brain metastases patients with and without radiotherapy: initial lessonsfrom a team-based consult service through a multidisciplinary integrated palliative oncology clinic.
Jung H; Sinnarajah A; Enns B; Voroney JP; Murray A; Pelletier G; Wu JS
Support Care Cancer; 2013 Dec; 21(12):3379-86. PubMed ID: 23934224
[TBL] [Abstract][Full Text] [Related]
28. Postoperative radiation for lung cancer metastatic to the brain.
Armstrong JG; Wronski M; Galicich J; Arbit E; Leibel SA; Burt M
J Clin Oncol; 1994 Nov; 12(11):2340-4. PubMed ID: 7964950
[TBL] [Abstract][Full Text] [Related]
29. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
Wong J; Hird A; Zhang L; Tsao M; Sinclair E; Barnes E; Danjoux C; Chow E
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1125-31. PubMed ID: 19231099
[TBL] [Abstract][Full Text] [Related]
30. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
[TBL] [Abstract][Full Text] [Related]
31. Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases.
Sabater S; Mur E; Müller K; Arenas M
Clin Transl Oncol; 2012 Jan; 14(1):43-9. PubMed ID: 22262718
[TBL] [Abstract][Full Text] [Related]
32. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Rades D; Pluemer A; Veninga T; Schild SE
Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
[TBL] [Abstract][Full Text] [Related]
33. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
35. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
Kundapur V; Ellchuk T; Ahmed S; Gondi V
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
[TBL] [Abstract][Full Text] [Related]
36. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
37. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
[TBL] [Abstract][Full Text] [Related]
38. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
39. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]